Showing results (1071-1080 of 9,901) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|February 18, 2004
Implications of early airflow decline after myeloablative allogeneic stem cell transplantationJ W Chien, P J Martin, M E Flowers, et al.
Bone Marrow Transplantation|February 18, 2004
Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT)A Al-Ahmari, M Ayas, A Al-Jefri, et al.
Bone Marrow Transplantation|December 1, 1992
A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibodyE G Rhodes, P K Baker, J K Duguid, et al.
Bone Marrow Transplantation|December 1, 1992
Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trialJ L Steegmann, J López, M J Otero, et al.
Bone Marrow Transplantation|April 6, 2004
Blood dendritic cells are decreased in acute graft-versus-host diseaseM Takebayashi, R Amakawa, K Tajima, et al.
Bone Marrow Transplantation|April 13, 2004
Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot studyS L Guthery, J E Heubi, A Filipovich
Bone Marrow Transplantation|April 13, 2004
High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remissionJ Mehta, R Powles, B Sirohi, et al.
Bone Marrow Transplantation|June 11, 2003
High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseasesC H McDonough, D A Jacobsohn, G B Vogelsang, et al.
Bone Marrow Transplantation|June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorH G Sayer, M Kröger, J Beyer, et al.
Bone Marrow Transplantation|June 11, 2003
Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study GroupV Akkari, J Donadieu, C Piguet, et al.
Pageof 991